Clinical Study

A Study To Evaluate An Oral Investigational Drug To See If It Helps Treat Symptoms In Adults With Adhd.

Posted Date: Jan 27, 2020

  • Investigator: Caleb Adler
  • Specialties: ADD/ADHD, Psychiatry/Psychology
  • Type of Study: Drug

A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults with Attention-deficit/Hyperactivity Disorder (Trial 405-201-00014)


18 To 55 Years Of Age, Diagnosis Of Adhd


Adult, Add, Adhd

For More Information:

Emily Rummelhoff

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.